real-world analysis of hodgkin lymphoma outcomes after auto-sct
Published 3 years ago • 310 plays • Length 7:35Download video MP4
Download video MP3
Similar videos
-
1:55
the real-world efficacy of brentuximab vedotin consolidation post-autosct in r/r hl
-
2:40
exploring the genomic landscape of hodgkin lymphoma with whole-genome sequencing
-
1:27
challenges in understanding the genomic landscape of hodgkin lymphoma
-
0:53
the current state of mrd in hodgkin lymphoma
-
20:34
hep b lab results interpretation case study: lab interpretation for nurse practitioners
-
6:53
my journey with pancreatic cancer diary pt 4
-
3:03
how bad is lymphoma cancer?
-
1:59
hodgkin lymphoma: prognostic markers in the era of novel treatments
-
1:37
the role of ctdna in hodgkin lymphoma
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
1:54
a retrospective analysis of real-world data from patients treated for r/r follicular lymphoma
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
3:09
treatment strategies for chl patients after auto-hsct
-
1:04
emerging concepts in hodgkin lymphoma
-
1:03
what’s on the horizon for hodgkin lymphoma?
-
1:19
real-world outcomes of liso-cel therapy in r/r dlbcl
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
5:28
blood review series – update on hodgkin lymphoma
-
1:15
biomarkers being explored in hodgkin lymphoma: the role of ctdna
-
1:57
the current hodgkin lymphoma immunotherapy landscape
-
1:26
improving tools and techniques for mrd detection in hodgkin lymphoma